[In conclusion, NCAM2 should be a novel gene therapy target for the treatment of prostate and breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE